Planet Labs PBC reports on July 9 with short sellers retreating into the print, options sentiment normalising, and the analyst community split sharply on whether the stock's 18% weekly surge reflects genuine re-rating or an overshoot.
The short-side story has shifted materially since the prior article published July 1. The put/call ratio — which briefly spiked to 0.60 on June 30, a four-standard-deviation extreme flagged as the most alarming signal heading into earnings week — has since collapsed back to 0.38, now sitting nearly one standard deviation below its 20-day average of 0.42. The defensive hedging that looked so urgent just days ago has dissipated almost entirely. Meanwhile, short interest has continued to ease, falling to 11.9% of the free float from 12% at the time of the prior note, and the ORTEX short score has drifted down to 61.5 from 64.2 a week ago. Borrow conditions remain relaxed: availability is running at 186% — well above the 52-week trough of 136% — and cost to borrow, while up 66% on the week, still prints a negligible 0.52%. The lending market is not flashing stress.
The bull-bear divide is where the genuine tension lives. Analysts who are constructive point to record Q2 revenue of $94.2M, up 42% year-on-year, a raised F27 guidance, an 8-figure European defence contract, and growing RPO as evidence that Planet's earth observation and AI-analytics platform is gaining real traction. Needham pushed its target to $53 after the last print; Craig-Hallum lifted to $49; Wedbush's Dan Ives reiterated Outperform at $50 as recently as July 1. Against a current price of $31.38, those targets imply 55-70% upside and reflect genuine conviction that the defence and intelligence tailwind is durable. Goldman Sachs sits firmly on the other side with a Neutral rating and a $20 target — a level the stock already traded well above — cautioning that rising competition and capital requirements to fulfil contracted demand will weigh on the path to profitability. EV/EBITDA near 267x and a price-to-book above 21x leave little margin for execution error.
The ownership picture adds one layer of interest. Alphabet remains the largest institutional holder at 9.9% of shares, and BlackRock added more than five million shares in the quarter to June 30, lifting its stake to 7.1%. That institutional accumulation at the top of the register is a quiet bullish signal. Founder and CEO Will Marshall and co-founder Robert Schingler both sold in June at prices near $30.58, as did CFO Ashley Johnson — routine-looking disposals, but notable as a cluster immediately ahead of an earnings release. The last print, on June 4, sent the stock down 25% on the day and a further 21% over the following five sessions, so the bar for a constructive reaction is real.
The July 9 print will test whether the revenue momentum and raised guidance can finally hold post-earnings, or whether the recurring pattern of selling into results reasserts itself at a stock still trading at a significant discount to even the most cautious analyst on the Street.
See the live data behind this article on ORTEX.
Open PL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
